Related Experiment Video

Updated: Apr 13, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

2.0K

Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy

Inge M Werter1, Famke L Schneiders1, Emmanuel Scotet2

  • 1Department of Medical Oncology; VU University Medical Center ; Amsterdam, The Netherlands.

Oncoimmunology
|May 6, 2015
PubMed

Keywords:
APCAPC, antigen presenting cellsAg, antigensBTN, butyrophilinBrHPP, bromohydrin pyrophosphateCD, Cluster of differentiationCD1dDN, double negativeGM-CSF, granulocyte-macrophage colony-stimulating factorIFNγ, interferon γIL, interleukineIPP, isopentenyl pyrophosphateMHC, major histocompatibility complexNK, natural killer cellsPBMC, peripheral blood mononuclear cellsTNFα, tumor necrosis factor αTh1, Type 1 T helperTh2, Type 2 T helperVγ9Vδ2-T cellsi.v., intravenousiNKTiNKT, invariant natural killer T cellsmoDC, monocyte derived dendritic cellspAg, phosphoantigenstrogocytosisα-GalCer, α-galactosylceramide

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.2K
Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product11:51

Expansion and Enrichment of Gamma-Delta γδ T Cells from Apheresed Human Product

Published on: September 22, 2021

10.1K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.4K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.8K